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Background: The major problem in ﬁghting inﬂuenza virus
is the high genetic variability which allows the virus to
infect new host species and quickly overcome protective
immunity.
Materials & Methods: Tat protein of human immunodeﬁ-
ciency virus (HIV) was fused to the epitopic segment of
the matrix gene of inﬂuenza A virus as the PTD domain,
cloned in pSecTag2 vector and expressed in MDCK cell line.
The fusion protein was isolated, puriﬁed and expressed
on antigen presenting cells (APCs) to generate immune
response against the virus infected cells.
Results: The sensitized dendritic cells (DCs), when co-
incubated with the cultured naive T cells, generated the
cytotoxic T lymphocytes (CTLs) against the virus infected
cells. The marked reduction in viral plaque count was
observed in lungs of Balb/c mice The real time RT PCR
assay also showed a signiﬁcant decrease in viral titer as
compared to the mock infected mouse. Cytokine analysis
of the BAL ﬂuid showed the enhanced expression of IFN-g,
IL-12, IL-10 and IL-4 as compared to control.
Conclusion: Thus, the protective effect was observed with
a single carrier protein coupled to the desired peptide
for priming the APCs and thus activating the host immune
system.
Figure 1. Cytotoxicity Assay with different strains of the virus.
Figure 2. Survival Assay with A/PR/8/34 (H1N1).
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Introduction: Human infection with the novel H1N1
inﬂuenza virus was ﬁrst reported in April 2009. Novel
Inﬂuenza A (H1N1) virus produces higher mortality in
young people. Different clinical manifestation of Inﬂuenza A
(H1N1) has been reported. We present encephalitis due
inﬂuenza A (H1N1) with good response to oseltamivir.
Case Description: The patient was a seven year-old girl
presented with mood change and gait ataxia from 5 days
before admission. She also had fever, delusion, and lethargy.
She had history of common cold several days before
admission. She was treated with acyclovir with impression of
encephalitis without improvement. In physical examination
(P/E) she was febrile, there was no nuchal rigidity. P/E
of chest, abdomen and extremities were normal. Lumbar
puncture was performed. Cerebrospinal ﬂuid (CSF) was
normal. CSF culture showed no growth after 48h. CBC,
FBS, BUN, Cr, Na, K, ALT, AST, CRP and procalcitonin were
all normal. HSV PCR was negative. Elecroencephalography
(EEG) was done that suggested encephalitis. Brain MRI was
normal. Throat culture was obtained for the diagnosis
of inﬂuenza A (H1N1) that was positive. The patient
was treated with oseltamivir. The patient recovered after
treatment and tests for equilibrium became normal.
Encephalitis due to inﬂuenza A (H1N1) should be considered
in every patient with signs and symptoms of encephalitis
during inﬂuenza A (H1N1) pandemy.
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Background: Current preventive measures are not effective
to confront inﬂuenza pandemic. Epidemiological studies
suggest that statin may protect people against inﬂuenza,
but there is no evidence on its anti-inﬂuenza effect in
animal models. This study is to identify anti-inﬂuenza virus
effect of statin in vivo.
Methods:
1. In H1N1 virus infection models of female BALB/c mice,
different concentration of statin and different treatment
(intragastric, intranasal/prevention, therapy) were given
to each group, ribavirin and oseltamivir were given
respectively as control.
2. Real-time RT-PCR (targeting the HA gene) was performed
to quantify changes in gene expression in groups with
different treatment.
3. Lung pathology tests were performed to grade the
inﬂammatory inﬁltration in each group.
Results:
1. The result of Real-time-PCR assay suggests that statin
can inhibit inﬂuenza virus replication.
2. Statin can signiﬁcantly reduce the lung pathology lesions
of H1N1 infection mice. It was to be more effective
when administered preventively than as treatment.
3. The anti-inﬂuenza effect of statin was comparable to
that of ribavirin and oseltamivir.
